Vertex Pharmaceuticals Inc 10-Q for FY2020 Q3
Vertex Pharmaceuticals Inc (VRTX)
10-Q
2020-10-30
For: 2020-09-30
View Original
Added on
April 02, 2026
About this 10-Q
Vertex Pharmaceuticals Inc filed this 10-Q on October 30, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.54B
- up 62.0% from $949.83M a year earlier
- Net income
- $667.43M
- up 1060.4% from net income of $57.52M a year earlier
- Diluted EPS
- $2.53
- up 1050.0% from $0.22 a year earlier